Usefulness of [18F]fluoro-2-deoxy-d-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 1, 2011, Pages 143-145

  Igai, Hitoshi ^a   Matsuura, Natsumi ^a   Tarumi, Shintaro ^a   Chang, Sung Soo ^a   Misaki, Noriyuki ^a   Go, Tetsuhiko ^a   Ishikawa, Shinya ^a   Yokomise, Hiroyasu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

18FDG PET; Thymic epithelial tumors; WHO classification

Indexed keywords

CARBOPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; PACLITAXEL; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYMECTOMY; THYMIC EPITHELIAL TUMOR; THYMOMA; THYMUS CARCINOMA; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR VOLUME; WORLD HEALTH ORGANIZATION; CANCER GRADING; CANCER STAGING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS;

EID: 79957996663     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.09.009     Document Type: Article

References (13)

1. Rosai J., Sobin L.H. Histological typing of tumours of thymus. international histological classification of tumours 1999, Springer, New York, p. 1-59. 2nd ed.
2. Travis W.D., Brambilla E., Mueller-Hermelink H.K., Harris C.C. WHO classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart 2004, IARC Press, Lyon.
3. Kondo K., Yoshizawa K., Tsuyuguchi M., Kimura S., Sumitomo M., Morita J., Miyoshi T., Sakiyama S., Mukai K., Monden Y. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 2004, 77:1183-1188.
4. Okumura M., Shinichiro M., Fujii Y., Takeuchi Y., Shiono H., Inoue M., Fukuhara K., Kadota Y., Tateyama H., Eimoto T., Matsuda H. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms. A study of 146 consecutive tumors. Am J Surg Pathol 2001, 25:103-110.
5. Duhaylongsod F.G., Lowe V.J., Patz E.F., Vaughn A.L., Coleman R.E., Wolfe W.G. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995, 60:1348-1352.
6. Nakata B., Chung Y.S., Nishimura S., Nishihara T., Sakurai Y., Sawada T., Okamura T., Kawabe J., Ochi H., Sowa M. 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma. Cancer 1997, 79:695-699.
7. Ahuja V., Coleman R.E., Herndon J., Patz E.F. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with non-small cell lung carcinoma. Cancer 1998, 83:918-924.
8. Endo M., Nakagawa K., Ohde Y., Okumura T., Kondo H., Igawa S., Nakamura Y., Tsuya A., Murakami H., Takahashi T., Yamamoto N., Ito I., Kameya T. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 2008, 61:350-355.
9. Sung Y.M., Lee K.S., Kim B.T., Choi J.Y., Shim Y.M., Yi C.A. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 2006, 47:1628-1634.
10. Inoue A., Tomiyama N., Tatsumi M. 18F-FDG PET for the evaluation of thymic epithelial tumours: correlation with the World Health Organization classification in addition to dual-time-point imaging. Eur J Nucl Med Mol Imaging 2009, 36:1219-1225.
11. Kumar A., Regmi S.K., Dutta R., Kumar R., Gupta S.D., Das P., Halanaik D., Jindal T. Characterization of thymic masses using 18F-FDG PET-CT. Ann Nucl Med 2009, 569-577.
12. Zasadny K.R., Wahl R.L. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose: variations with body weight and a method for correction. Radiology 1993, 189:847-850.
13. Lindholm P., Minn H., Leskinen-Kallio S., Bergmann J., Ruotsalainen U., Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer: a PET study. J Nucl Med 1993, 34:1-6.